181 related articles for article (PubMed ID: 15274070)
1. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
Offidani M; Corvatta L; Malerba L; Marconi M; Bichisecchi E; Cecchini S; Manso E; Principi T; Gasparini S; Leoni P
Cancer; 2004 Aug; 101(3):567-77. PubMed ID: 15274070
[TBL] [Abstract][Full Text] [Related]
2. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
von Lilienfeld-Toal M; Glasmacher A
Cancer; 2005 Feb; 103(4):874; discussion 875. PubMed ID: 15611970
[No Abstract] [Full Text] [Related]
4. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
5. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
6. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients.
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2007 Aug; 63(2):344-50. PubMed ID: 17693834
[TBL] [Abstract][Full Text] [Related]
9. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
Cherif H; Johansson E; Björkholm M; Kalin M
Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
12. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
Rondinelli PI; Ribeiro Kde C; de Camargo B
J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
[TBL] [Abstract][Full Text] [Related]
13. Posttraumatic cerebral infarction: incidence, outcome, and risk factors.
Tawil I; Stein DM; Mirvis SE; Scalea TM
J Trauma; 2008 Apr; 64(4):849-53. PubMed ID: 18404047
[TBL] [Abstract][Full Text] [Related]
14. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
Borg C; Ray-Coquard I; Philip I; Clapisson G; Bendriss-Vermare N; Menetrier-Caux C; Sebban C; Biron P; Blay JY
Cancer; 2004 Dec; 101(11):2675-80. PubMed ID: 15503313
[TBL] [Abstract][Full Text] [Related]
15. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic risk factors for serious complications in an inpatient population with neutropenia at the onset of a febrile episode].
Gómez Roca C; Rivero M; Hugo K; Novillo A; Marta Lapadula M; Recondo G; Milberg M
Medicina (B Aires); 2006; 66(5):385-91. PubMed ID: 17137166
[TBL] [Abstract][Full Text] [Related]
17. The Thoracic Surgery Scoring System (Thoracoscore): risk model for in-hospital death in 15,183 patients requiring thoracic surgery.
Falcoz PE; Conti M; Brouchet L; Chocron S; Puyraveau M; Mercier M; Etievent JP; Dahan M
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):325-32. PubMed ID: 17258556
[TBL] [Abstract][Full Text] [Related]
18. Early impairment in consciousness predicts mortality after hemispheric ischemic stroke.
Cucchiara BL; Kasner SE; Wolk DA; Lyden PD; Knappertz VA; Ashwood T; Odergren T; Nordlund A;
Crit Care Med; 2004 Jan; 32(1):241-5. PubMed ID: 14707586
[TBL] [Abstract][Full Text] [Related]
19. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass.
DeMaria EJ; Portenier D; Wolfe L
Surg Obes Relat Dis; 2007; 3(2):134-40. PubMed ID: 17386394
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
